Short-Interval ctDNA Testing Rapid Monitoring of Tumor Response in GI Cancer – Sakti Chakrabarti, MD ASCO GI Gastrointestinal 2 Mins Read Abstract: Circulating tumor DNA (ctDNA) has a short half-life (<2 hours) which may permit real-time monitoring of tumor status. This…
Pashtoon Kasi MD, MS – The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Management – ASCO GI 2025 Colorectal 4 Mins Read In the evolving landscape of cancer care In the evolving landscape of cancer care, the use of circulating tumor DNA…
Celecoxib / Celebrex & ctDNA in Stage III Colon Cancer Findings from CALGB Alliance / SWOG 80702 ASCO GI 2025 Gastrointestinal 3 Mins Read In an enlightening discussion at the latest medical symposium, Dr. Jonathan Nowak, MD from Brigham and Women’s Hospital, shared critical…
